ERLEADA (apalutamide)

SELF ADMINISTRATION

Indications for Prior Authorization:

  • Treatment of patients with non-metastatic castration-resistant prostate cancer (NM-CRPC)

Patients must meet the following criteria for the indication(s) above:

  • Diagnosis of non-metastatic, castration-resistant prostate cancer (NM-CRPC), AND
  • Prescribed by or in consultation with an oncologist or urologist, AND
  • Patient will receive a gonadotropin-releasing hormone (GnRH) analog concurrently or has had bilateral orchiectomy

Dosing:

  • 240 mg (four 60mg tablets) once daily
  • Bone support should be used in patients receiving Erleada

Approval:

  • 1 year

Last review date: April 23, 2019

Rite Aid Pharmacy Patients: All Rite Aid pharmacies nationwide are closing! Please be on the lookout for information from Rite Aid pharmacies about their bankruptcy and store closures. Call your Rite Aid pharmacy for questions about your prescriptions and new pharmacy options. WHA is here to help as well. Contact Us via Phone